These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20857513)

  • 21. The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions.
    Uchida T; Popma J; Stone GW; Ellis SG; Turco MA; Ormiston JA; Muramatsu T; Nakamura M; Nanto S; Yokoi H; Baim DS
    JACC Cardiovasc Interv; 2010 Apr; 3(4):403-11. PubMed ID: 20398868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
    Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-year outcomes of the sirolimus-eluting stent according to unprotected left main lesion.
    Kim U; Park JS; Seol SH; Yang TH; Kim SM; Kim DK; Kim DI; Kim DS; Lee WJ; Lee SH; Hong GR; Shin DG; Kim YJ; Shim BS; Cho YK; Kim HS; Nam CW; Hur SH; Kim KB; Kim YN
    Clin Cardiol; 2009 Jun; 32(6):332-6. PubMed ID: 19569064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term clinical and angiographic outcomes after implantation of sirolimus-eluting stents with a "modified mini-crush" technique in coronary bifurcation lesions.
    Yang HM; Tahk SJ; Woo SI; Lim HS; Choi BJ; Choi SY; Yoon MH; Park JS; Zheng M; Hwang GS; Kang SJ; Shin JH
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):76-84. PubMed ID: 19360861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudy.
    Wykrzykowska JJ; Serruys PW; Onuma Y; de Vries T; van Es GA; Buszman P; Linke A; Ischinger T; Klauss V; Corti R; Eberli F; Wijns W; Morice MC; di Mario C; van Geuns RJ; Juni P; Windecker S
    JACC Cardiovasc Interv; 2009 Sep; 2(9):861-70. PubMed ID: 19778775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial.
    Lemos PA; Moulin B; Perin MA; Oliveira LA; Arruda JA; Lima VC; Lima AA; Caramori PR; Medeiros CR; Barbosa MR; Brito FS; Ribeiro EE; Martinez EE;
    Catheter Cardiovasc Interv; 2009 Nov; 74(5):665-73. PubMed ID: 19670303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of coronary bifurcation angle on clinical outcomes in Chinese patients treated with crush stenting: a subgroup analysis from DKCRUSH-1 bifurcation study.
    Chen SL; Zhang JJ; Ye F; Chen YD; Fang WY; Wei M; He B; Sun XW; Yang S; Chen JG; Shan SJ; Tian NL; Li XB; Liu ZZ; Kan J; Michael L; W KT
    Chin Med J (Engl); 2009 Feb; 122(4):396-402. PubMed ID: 19302743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and angiographic outcomes of drug-eluting stents in patients with large vessel and single coronary artery lesion.
    Kim U; Kim DK; Seol SH; Yang TH; Kim DK; Kim DI; Kim DS; Lee SH; Hong GR; Park JS; Shin DG; Kim YJ; Cho YK; Kim HS; Nam CW; Hur SH; Kim KB
    Clin Cardiol; 2010 Jun; 33(6):340-4. PubMed ID: 20556803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of stent length on restenosis in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: analysis based on data from the Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON).
    Rozenman Y; Witzling V; Tamari I; Turkisher V; Kriviski M; Bode C; Henry P; Teiger E; Cebrian A; Stoll HP; Spaulding C
    EuroIntervention; 2009 Jun; 5(2):219-23. PubMed ID: 19527979
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized Comparisons Between Different Stenting Approaches for Bifurcation Coronary Lesions With or Without Side Branch Stenosis.
    Kim YH; Lee JH; Roh JH; Ahn JM; Yoon SH; Park DW; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Seung KB; Shin WY; Lee NH; Lee BK; Lee SG; Nam CW; Yoon J; Yang JY; Hyon MS; Lee K; Jang JS; Kim HS; Park SW; Park SJ
    JACC Cardiovasc Interv; 2015 Apr; 8(4):550-60. PubMed ID: 25907082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy.
    Wykrzykowska JJ; Räber L; de Vries T; Bressers M; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Corti R; Wijns W; Morice MC; di Mario C; Regar E; Jüni P; Windecker S; Serruys PW
    EuroIntervention; 2009 Aug; 5(3):310-7. PubMed ID: 19736154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term clinical and angiographic outcomes of diabetic patients after revascularization with early generation drug-eluting stents.
    Billinger M; Räber L; Hitz S; Stefanini GG; Pilgrim T; Stettler C; Zanchin T; Pulver C; Pfäffli N; Eberli F; Meier B; Kalesan B; Jüni P; Windecker S
    Am Heart J; 2012 May; 163(5):876-886.e2. PubMed ID: 22607867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug eluting stenting in bifurcation coronary lesions long-term results applying a systematic treatment strategy.
    Assali AR; Vaknin-Assa H; Lev E; Teplitsky I; Dvir D; Brosh D; Bental T; Battler A; Kornowski R
    Catheter Cardiovasc Interv; 2012 Mar; 79(4):615-22. PubMed ID: 22162218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early and long-term results of unprotected left main coronary artery stenosis with paclitaxel-eluting stents: the FRIEND (French multicentre RegIstry for stenting of uNprotecteD LMCA stenosis) registry.
    Carrié D; Eltchaninoff H; Lefèvre T; Silvestri M; Brunel P; Fajadet J; Moynagh A; Gilard M; Koning R; Dibie A; Darremont O; Lablanche JM; Blanchard D;
    EuroIntervention; 2011 Oct; 7(6):680-8. PubMed ID: 21986326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of three-year clinical outcomes between sirolimus-versus paclitaxel-eluting stents in diabetic patients: prospective randomized multicenter trial.
    Hong SJ; Kim MH; Cha KS; Park HS; Chae SC; Hur SH; Gwon HC; Bae JH; Lim DS
    Catheter Cardiovasc Interv; 2010 Dec; 76(7):924-33. PubMed ID: 20815045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.
    Chen SL; Chen JP; Mintz G; Xu B; Kan J; Ye F; Zhang J; Sun X; Xu Y; Jiang Q; Zhang A; Stone GW
    JACC Cardiovasc Interv; 2010 Jun; 3(6):632-41. PubMed ID: 20630456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
    Kandzari DE; Mauri L; Popma JJ; Turco MA; Gurbel PA; Fitzgerald PJ; Leon MB
    JACC Cardiovasc Interv; 2011 May; 4(5):543-50. PubMed ID: 21596327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up (four years) of unprotected left main coronary artery disease treated with paclitaxel-eluting stents (from the TRUE Registry).
    Godino C; Parodi G; Furuichi S; Latib A; Barbagallo R; Goktekin O; Cera M; Mueller R; Tamburino C; Grube E; Di Mario C; Reimers B; Chieffo A; Antoniucci D; Colombo A; Sangiorgi GM
    EuroIntervention; 2010 Apr; 5(8):906-16. PubMed ID: 20542775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
    Onuma Y; Girasis C; Piazza N; Garcia-Garcia HM; Kukreja N; Garg S; Eindhoven J; Cheng JM; Valgimigli M; van Domburg R; Serruys PW;
    JACC Cardiovasc Interv; 2010 Jun; 3(6):584-94. PubMed ID: 20630451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute and long-term outcomes of ostial stentings among bare-metal stents, sirolimus-eluting stents, and paclitaxel-eluting stents.
    Hsieh IC; Hsieh MJ; Chang SH; Wang CY; Lee CH; Lin FC; Chen CC
    Coron Artery Dis; 2013 May; 24(3):224-30. PubMed ID: 23571311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.